Immunotherapy associated Sweet syndrome in a patient with metastatic melanoma: A case report

• Prif Awduron: Rory Barry (Awdur), Gregg Murray (Awdur), Sally McGrath (Awdur), Clive Kilgallen (Awdur), Karen Eustace (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Wiley, 2024-09-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Abstract Immunotherapy agents are now widely used in the treatment of metastatic melanoma. Immune‐related adverse events (irAEs) may occur, including cutaneous pathologies in 50% of patients. We report a case of Sweet syndrome (SS) in a patient who was prescribed ipilimumab and nivolumab for metasta...